CSL 0.82% $274.49 csl limited

'There will be enough': CSL to hit record flu vaccine production

  1. 846 Posts.
    lightbulb Created with Sketch. 529

    https://www.theage.com.au/business/companies/there-will-be-enough-csl-to-hit-record-flu-vaccine-production-20200419-p54l49.html


    CSL's flu vaccine arm Seqirus has assured Australians there will enough flu vaccines to go around, but people may have to wait as the company commits to ramping up production with another 2 million doses.

    Seqirus, which is owned by biotechnology giant CSL, produces the flu vaccine for both the southern and northern hemisphere flu seasons. Ms Dowell said the company had put together a global plan to ensure it can supply both markets adequately this year. Vaccine production for the northern hemisphere's flu season had already begun but has been paused to ensure the 2 million additional doses are completed for Australia."That’s the challenge for us, and we're trying to balance that," Ms Dowell said.
 
watchlist Created with Sketch. Add CSL (ASX) to my watchlist
(20min delay)
Last
$274.49
Change
-2.270(0.82%)
Mkt cap ! $132.6B
Open High Low Value Volume
$274.92 $276.28 $274.08 $101.1M 368.0K

Buyers (Bids)

No. Vol. Price($)
1 887 $274.29
 

Sellers (Offers)

Price($) Vol. No.
$274.58 6 1
View Market Depth
Last trade - 16.10pm 01/05/2024 (20 minute delay) ?
Last
$274.42
  Change
-2.270 ( 0.76 %)
Open High Low Volume
$274.75 $276.24 $274.09 29594
Last updated 15.59pm 01/05/2024 ?
CSL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.